Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells

Zhe Dai,Xu-yu Gu,Shou-yan Xiang,Dan-dan Gong,Chang-feng Man,Yu Fan
DOI: https://doi.org/10.1186/s40364-020-00240-1
2020-11-10
Biomarker Research
Abstract:Abstract Malignant tumor is a largely harmful disease worldwide. The cure rate of malignant tumors increases with the continuous discovery of anti-tumor drugs and the optimisation of chemotherapy options. However, drug resistance of tumor cells remains a massive obstacle in the treatment of anti-tumor drugs. The heterogeneity of malignant tumors makes studying it further difficult for us. In recent years, using single-cell sequencing technology to study and analyse circulating tumor cells can avoid the interference of tumor heterogeneity and provide a new perspective for us to understand tumor drug resistance.
oncology,medicine, research & experimental
What problem does this paper attempt to address?